What this means
This study plans to offer recommended vaccines to adults and older patients with long-term illness at a single hospital. It has not started yet, so it cannot yet show whether the plan works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 18 and over
- Where
- Not listed
The science
- Registered title
- Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients
- Trial ID
- NCT07391046 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Chronic Disease, Immunocompromised, HIV Infection, Chronic Kidney Disease, Solid Organ Transplantation, Hematopoietic Stem Cell Transplantation, Cancer, Autoimmune Diseases, Inflammatory Bowel Disease, Asplenia, Frailty
- What is tested
- Hospital-Based Vaccination Pathway
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Ages
- 18 Years to no maximum
- Dates
- First posted Feb 5, 2026 · updated Feb 5, 2026
Registry summary
AMBU-VAX is a prospective, single-center observational study designed to develop and implement an organizational model for delivering recommended vaccinations within a hospital setting.
The study targets adult and elderly patients with chronic diseases or immunocompromising conditions who are eligible for vaccination according to national immunization guidelines. Vaccination is actively proposed during outpatient visits, hospital admissions, or at discharge and, when accepted, administered within the hospital or coordinated with local public health vaccination services.
The study aims to evaluate the feasibility, uptake, and completion of hospital-based vaccination pathways and to support integration between hospital and territorial prevention services for vulnerable populations.